Dr. Galen Wright is an assistant professor in pharmacology and therapeutics at the University of Manitoba and is currently a Canada Research Chair in neurogenomics. He completed his PhD in genetics at Stellenbosch University, and received additional training in computational biology at the South African National Bioinformatics Institute. Dr. Wright then conducted a postdoctoral fellowship at the University of British Columbia. This fellowship led to the identification of highly predictive genetic biomarkers for various adverse drug reactions, including drug-induced neurotoxicities. Further, his precision medicine research has also involved the investigation of genetic variants which modify the age of onset of the neurodegenerative disorder, Huntington disease. This research identified clinically-relevant genetic variants for this trait.